产品标题 产品货号 产品规格 厂家
Human coiled-coil-helix-coiled-coil-helix domain containing 3 (CHCHD3) from ORIGENE TECHNOLOGIESTP30017420 ugORIGENE TECHNOLOGIES
Human coiled-coil-helix-coiled-coil-helix domain containing 5 (CHCHD5) from ORIGENE TECHNOLOGIESTP30260620 ugORIGENE TECHNOLOGIES
Human coiled-coil-helix-coiled-coil-helix domain containing 4 (CHCHD4), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESTP31783120 ugORIGENE TECHNOLOGIES
Human cold shock domain containing C2, RNA binding (CSDC2) from ORIGENE TECHNOLOGIESTP30898920 ugORIGENE TECHNOLOGIES
Human cold inducible RNA binding protein (CIRBP), transcript variant 1 from ORIGENE TECHNOLOGIESTP30163920 ugORIGENE TECHNOLOGIES
Human cold shock domain containing C2, RNA binding (CSDC2), full length from ORIGENE TECHNOLOGIESTP71014620 ugORIGENE TECHNOLOGIES
Human cold shock domain containing E1, RNA-binding (CSDE1), transcript variant 2 from ORIGENE TECHNOLOGIESTP30710120 ugORIGENE TECHNOLOGIES
Human coiled-coil-helix-coiled-coil-helix domain containing 6 (CHCHD6) from ORIGENE TECHNOLOGIESTP30297520 ugORIGENE TECHNOLOGIES
Human colipase, pancreatic (CLPS) from ORIGENE TECHNOLOGIESTP30500420 ugORIGENE TECHNOLOGIES
Human cold shock domain protein A (CSDA), transcript variant 1 from ORIGENE TECHNOLOGIESTP30585620 ugORIGENE TECHNOLOGIES
Human collagen, type III, alpha 1 (COL3A1) from ORIGENE TECHNOLOGIESTP31176620 ugORIGENE TECHNOLOGIES
Human collagen, type IV, alpha 3 (Goodpasture antigen) binding protein (COL4A3BP), transcript variant 2 from ORIGENE TECHNOLOGIESTP30031620 ugORIGENE TECHNOLOGIES
Human collagen, type IX, alpha 1 (COL9A1), transcript variant 1 from ORIGENE TECHNOLOGIESTP31813020 ugORIGENE TECHNOLOGIES
Human collagen triple helix repeat containing 1 (CTHRC1) from ORIGENE TECHNOLOGIESTP30434820 ugORIGENE TECHNOLOGIES
Human collagen, type IX, alpha 3 (COL9A3) from ORIGENE TECHNOLOGIESTP30401020 ugORIGENE TECHNOLOGIES
Human collagen, type IX, alpha 1 (COL9A1), transcript variant 2 from ORIGENE TECHNOLOGIESTP30947320 ugORIGENE TECHNOLOGIES
Human collagen, type VI, alpha 1 (COL6A1) from ORIGENE TECHNOLOGIESTP30856220 ugORIGENE TECHNOLOGIES
Human collagen, type VI, alpha 2 (COL6A2), transcript variant 2C2 from ORIGENE TECHNOLOGIESTP30947620 ugORIGENE TECHNOLOGIES
Human collagen, type VIII, alpha 2 (COL8A2) from ORIGENE TECHNOLOGIESTP31600320 ugORIGENE TECHNOLOGIES
Human collagen, type VI, alpha 2 (COL6A2), transcript variant 2C2a from ORIGENE TECHNOLOGIESTP31870420 ugORIGENE TECHNOLOGIES
Human collagen, type X, alpha 1 (COL10A1) from ORIGENE TECHNOLOGIESTP31165820 ugORIGENE TECHNOLOGIES
Human collagen, type XV, alpha 1 (COL15A1) from ORIGENE TECHNOLOGIESTP31598120 ugORIGENE TECHNOLOGIES
Human collagen, type XVIII, alpha 1 (COL18A1), transcript variant 2. from ORIGENE TECHNOLOGIESTP72307720 ugORIGENE TECHNOLOGIES
Human collagen, type XXI, alpha 1 (COL21A1) from ORIGENE TECHNOLOGIESTP31572420 ugORIGENE TECHNOLOGIES
Human collagen, type XXVIII, alpha 1 (COL28A1) from ORIGENE TECHNOLOGIESTP31536420 ugORIGENE TECHNOLOGIES
Human collagen, type XXIII, alpha 1 (COL23A1) from ORIGENE TECHNOLOGIESTP32053520 ugORIGENE TECHNOLOGIES
Human collapsin response mediator protein 1 (CRMP1), transcript variant 2 from ORIGENE TECHNOLOGIESTP30048320 ugORIGENE TECHNOLOGIES
Human collectin sub-family member 12 (COLEC12) from ORIGENE TECHNOLOGIESTP30920120 ugORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma in situ of colon from ORIGENE TECHNOLOGIESCS6371055x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS7075505x5umORIGENE TECHNOLOGIES
Human collectin sub-family member 11 (COLEC11), transcript variant 2 from ORIGENE TECHNOLOGIESTP30319920 ugORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS7078125x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS7075515x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6000375x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS7079935x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6001545x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6005815x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6002135x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6010395x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS8046995x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6039025x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6035895x5umORIGENE TECHNOLOGIES
Human Colon; Adenocarcinoma, metastatic, consistent with colon primary from ORIGENE TECHNOLOGIESCS6160805x5umORIGENE TECHNOLOGIES
TM9SF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4020481 kitORIGENE TECHNOLOGIES
TM4SF4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4003461 kitORIGENE TECHNOLOGIES
TM7SF2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4021161 kitORIGENE TECHNOLOGIES
TM9SF4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4036481 kitORIGENE TECHNOLOGIES
TM4SF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4059341 kitORIGENE TECHNOLOGIES
TM4SF5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4101401 kitORIGENE TECHNOLOGIES
TM4SF18 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4050291 kitORIGENE TECHNOLOGIES
 |< < 4375 4376 4377 4378 4379 4380 4381 4382 4383 > >| 第 4377/6274 页